HSIA DAVID C 4
4 · WATSON PHARMACEUTICALS INC · Filed Nov 14, 2003
Insider Transaction Report
Form 4
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
- Sale
Common Stock, par value $0.0033
2003-11-13$45.00/sh−1,250$56,250→ 597,814 total(indirect: By Trust)
Holdings
- 60,000
Common Stock, par value $0.0033
- 40,000(indirect: By Trust)
Common Stock, par value $0.0033
Footnotes (1)
- [F1]1. The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans dated August 27, 2003.